BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4452557)

  • 1. Evidence for tumor-specific antigens in filtered tissue culture media from human cancer cells.
    Hickok DF; Miller L
    In Vitro; 1974; 10(3-4):157-66. PubMed ID: 4452557
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a new oncofoetal antigen associated with several types of human carcinomas.
    Fritsché R; Mach J
    Nature; 1975 Dec; 258(5537):734-7. PubMed ID: 1207757
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
    Fink LM; Clarke SM
    Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of antigen-antibody complexes in cancer patients.
    Rossen RD
    Antibiot Chemother (1971); 1978; 22():5-15. PubMed ID: 341797
    [No Abstract]   [Full Text] [Related]  

  • 6. Human cancers transplanted in nude mice retain the expression of their organ-specific neoantigens.
    Thomson DM; Neville AM; Phelan K; Scanzano RS; Vandevoorde JP
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1191-7. PubMed ID: 7199466
    [No Abstract]   [Full Text] [Related]  

  • 7. Human monoclonal antibody to a neuroectodermal tumor antigen (OFA-I-2).
    Katano M; Sidell N; Irie RF
    Ann N Y Acad Sci; 1983; 417():427-34. PubMed ID: 6584083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypersensitivity skin reactions to antigens on human tumors.
    Herberman RB
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for the expression of human tumor-specific antigens associated with beta2-microglobulin in human cancer and in some colon adenomas and benign breast lesions.
    Thomson DM; Tataryn DN; O'Connor R; Rauch J; Friedlander P; Gold P; Shuster J
    Cancer Res; 1979 Feb; 39(2 Pt 2):604-11. PubMed ID: 83913
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble membrane antigens of human malignant melanoma cells.
    Hollinshead AC; Herberman RB; Jaffurs WJ; Alpert LK; Minton JP; Harris JE
    Cancer; 1974 Oct; 34(4):1235-43. PubMed ID: 4418174
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
    Weese JL; Herberman RB; Hollinshead AC; Cannon GB; Keels M; Kibrite A; Morales A; Char DH; Oldham RK
    J Natl Cancer Inst; 1978 Feb; 60(2):255-63. PubMed ID: 74413
    [No Abstract]   [Full Text] [Related]  

  • 14. Apparent tumour specificity with the SCM test.
    Cercek L; Cercek B
    Br J Cancer; 1975 Feb; 31(2):252-3. PubMed ID: 1164473
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
    Hollinshead AC
    Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons.
    Greiner JW; Schlom J; Pestka S; Langer JA; Giacomini P; Kusama M; Ferrone S; Fisher PB
    Pharmacol Ther; 1985; 31(3):209-36. PubMed ID: 3843352
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation of viable from non-viable tumor cells using Ficoll-Hypaque density solution.
    Mavligit GM; Gutterman JU; Hersh EM
    Immunol Commun; 1973; 2(5):463-72. PubMed ID: 4518928
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of carcinoembryonic antigen in the media of cultures of carcinomatous cells of digestive-system origin.
    Laing CA; Heppner GH; Kopp LE; Calabresi P
    J Natl Cancer Inst; 1972 Jun; 48(6):1909-11. PubMed ID: 5066473
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.